JP2016537979A5 - - Google Patents

Download PDF

Info

Publication number
JP2016537979A5
JP2016537979A5 JP2016531660A JP2016531660A JP2016537979A5 JP 2016537979 A5 JP2016537979 A5 JP 2016537979A5 JP 2016531660 A JP2016531660 A JP 2016531660A JP 2016531660 A JP2016531660 A JP 2016531660A JP 2016537979 A5 JP2016537979 A5 JP 2016537979A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
polypeptide
sequence
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016531660A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016537979A (ja
JP6745720B2 (ja
Filing date
Publication date
Priority claimed from PCT/EP2013/073869 external-priority patent/WO2015070911A1/en
Application filed filed Critical
Publication of JP2016537979A publication Critical patent/JP2016537979A/ja
Publication of JP2016537979A5 publication Critical patent/JP2016537979A5/ja
Application granted granted Critical
Publication of JP6745720B2 publication Critical patent/JP6745720B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016531660A 2013-11-14 2014-11-14 改変されたkz144エンドリシン配列 Active JP6745720B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2013/073869 WO2015070911A1 (en) 2013-11-14 2013-11-14 Modified kz144 endolysin sequence
EPPCT/EP2013/073869 2013-11-14
PCT/EP2014/074671 WO2015071436A1 (en) 2013-11-14 2014-11-14 Modified kz144 endolysin sequence

Publications (3)

Publication Number Publication Date
JP2016537979A JP2016537979A (ja) 2016-12-08
JP2016537979A5 true JP2016537979A5 (cg-RX-API-DMAC7.html) 2017-12-07
JP6745720B2 JP6745720B2 (ja) 2020-08-26

Family

ID=49582760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016531660A Active JP6745720B2 (ja) 2013-11-14 2014-11-14 改変されたkz144エンドリシン配列

Country Status (10)

Country Link
US (1) US10184120B2 (cg-RX-API-DMAC7.html)
JP (1) JP6745720B2 (cg-RX-API-DMAC7.html)
KR (1) KR102302044B1 (cg-RX-API-DMAC7.html)
CN (1) CN105793419B (cg-RX-API-DMAC7.html)
AU (1) AU2014350104B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016011091B1 (cg-RX-API-DMAC7.html)
CA (1) CA2929686C (cg-RX-API-DMAC7.html)
EA (1) EA035959B1 (cg-RX-API-DMAC7.html)
MX (1) MX374403B (cg-RX-API-DMAC7.html)
WO (2) WO2015070911A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2934714T3 (es) 2015-09-17 2023-02-24 Contrafect Corp Polipéptidos de lisina activos contra bacterias Gram-negativas
AU2017255962B2 (en) * 2016-04-28 2023-02-23 Lysando Ag Antimicrobial agents against Salmonella bacteria
EP3464583A1 (en) 2016-05-27 2019-04-10 Sasinapas Co., Ltd. Endolysin variant
WO2018100408A1 (en) * 2016-11-30 2018-06-07 Sasinapas Co.,Ltd. Modified peptides
KR20240162610A (ko) * 2017-04-03 2024-11-15 사시나파스 컴퍼니 리미티드 조작된 그람-음성 엔도리신
US20210198645A1 (en) * 2018-05-30 2021-07-01 Lysando Ag Novel antimicrobial fusion proteins
CN111304181B (zh) * 2020-02-17 2021-11-23 华东理工大学 一种基因工程改造后的副溶血性弧菌噬菌体裂解酶及其制备方法和应用
KR20250044545A (ko) 2023-09-23 2025-04-01 조배근 사료급이기 청소기

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1289092C (en) * 1987-01-15 1991-09-17 Novartis Vaccines And Diagnostics, Inc. Thermostable human cu/zn superoxide dismutase muteins
EP0285123A3 (en) 1987-04-03 1989-02-01 Stabra AG A method for complete mutagenesis of nucleic acids
ZA936811B (en) * 1992-10-28 1995-03-15 Upjohn Co Somatotropin modifications
JPH08127540A (ja) * 1994-09-09 1996-05-21 Takeda Chem Ind Ltd 抗潰瘍医薬
CN101952424A (zh) * 2007-08-22 2011-01-19 海格罗斯投资有限责任公司 用于人类和动物葡萄球菌感染的新蛋白
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
US20120195872A1 (en) 2009-06-26 2012-08-02 Lysando Ag Antimicrobial agents
PL2445515T3 (pl) * 2009-06-26 2016-10-31 Środki przeciwdrobnoustrojowe
JP5847081B2 (ja) * 2009-08-24 2016-01-20 カトリック ユニバーシテイト ルーベン ケイ.ユー. ルーベン アール アンド ディー エンドリシンOBPgpLYS
DK2563916T3 (en) * 2010-04-27 2015-10-05 Lysando Ag METHOD FOR REDUCING biofilms
GB201018518D0 (en) * 2010-11-03 2010-12-15 Univ Leuven Kath Novel endolysin
EP2468856A1 (en) 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Antimicrobial Agents
KR20130142837A (ko) * 2012-06-20 2013-12-30 한국외국어대학교 연구산학협력단 슈도모나스 에루기노사의 박테리오파아지 및 그 용도

Similar Documents

Publication Publication Date Title
Sinha et al. Antimicrobial lactoferrin peptides: the hidden players in the protective function of a multifunctional protein
JP2014500714A5 (cg-RX-API-DMAC7.html)
Rai Peptide and protein mimetics by retro and retroinverso analogs
Pärn et al. The antimicrobial and antiviral applications of cell-penetrating peptides
NZ704191A (en) Cell-penetrating peptides and uses therof
JP2012530510A5 (cg-RX-API-DMAC7.html)
SA522433360B1 (ar) L-أَسْباراجيناز مُعدل
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
JP2019526248A5 (cg-RX-API-DMAC7.html)
JP2014508510A5 (cg-RX-API-DMAC7.html)
JP2015525217A5 (cg-RX-API-DMAC7.html)
JP2015212284A5 (cg-RX-API-DMAC7.html)
Ryge et al. New indolicidin analogues with potent antibacterial activity
JP2015524403A5 (cg-RX-API-DMAC7.html)
NZ602943A (en) Modified binding proteins inhibiting the vegf-a receptor interaction
HRP20240135T1 (hr) Fgf21 mutanti i njihove upotrebe
JP2019534884A5 (cg-RX-API-DMAC7.html)
JP2023528207A5 (cg-RX-API-DMAC7.html)
JP2018538356A5 (cg-RX-API-DMAC7.html)
JP2017524380A5 (ja) 腫瘍血管遮断剤であるポリペプチド、遺伝子、発現ベクター、腫瘍血管遮断剤の組成物、及び腫瘍血管遮断剤であるポリペプチドの調製方法
JP2024041747A5 (cg-RX-API-DMAC7.html)
JP2010530903A5 (cg-RX-API-DMAC7.html)
EA201990856A1 (ru) Новые противомикробные агенты против бактерий enterococcus
JP2014519526A5 (cg-RX-API-DMAC7.html)
WO2011135222A3 (fr) Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles